VINCENT HILLENMEYER France

H4D H4D provides easy and convenient access to a physician through a connected telehealth kiosk, the Consult Station, supported by a best-in-class technology platform. Industry sectors E health Therapeutics Area Cardiology / Vascular Diseases
Dermatology
Infectious Diseases - Vaccines
Nutrition and Weight Loss
Ophthalmology
Otolaryngology (Ear, Nose, Throat)
Pulmonary/Respiratory Diseases
Psychiatry/Psychology
Your innovative solution

The Consult Station

Which problem are you solving ?

Access to care is an increasing challenge throughout the world at a time when chronic diseases, an ageing population and increasing costs challenge current medical organizations. H4D

Target market segments

Corporations, hospitals, retirement communities, rural and remote areas.

Key value proposition

1) Quality and certification for professional medical use, 2) Large functional coverage for primary care uses, 3) Convenient and easy access to a physician, 4) Cost savings.

H4D
COO 

Dr David Hirsh United States

Inflammation is the mammalian response to infection. Normally it is defensive and thwarts pathogenic assaults but occasionally it runs amok, leading to physiological chaos and death. We are interested in the regulation of the inflammatory pathway as mediated by various cytokines. We focus on the regulation of interleukin-1 by the interleukin-1 receptor antagonist, determine its interactions with other cytokines and assay the cellular and molecular consequences when interleukin expression is altered. Transgenic mice and mice deleted for genes encoding these regulatory molecules have been generated and we utilize them as tools for deciphering these inflammatory pathways.

Cells use receptor mediated endocytosis to take up proteins from their environment, be it for antigen processing, polypeptide hormone signaling, nutrient supplementation, growth factor stimulation or receptor modulation. We are studying the endocytic pathway and receptor recycling using a molecular genetic analysis in the model organism, C. elegans. Our purpose is to identify new key molecular components in the pathway and to elucidate their structures and functions.

Columbia University | DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOPHYSICS
Professor 

Steve Hochberg United States

Industry

Investment Management

Specialties

Investment, Information, Philanthropy, Healthcare

We seek to advance healthcare through investment, information and philanthropy. At Deerfield, we owe our success to our team-oriented process, which brings together many decades of experience, across all sub-sectors of healthcare, to deliver our clients with the best funding solutions possible. 

We are a non-activist, relationship-focused firm who is proud to help the companies we invest in, because we see their potential to advance healthcare and drive change in this crucial industry.

Deerfield Management
Partner 

Mr Michael Hochstat United States

WBB Securities is a leading investment management, investment banking, and equity research firm.  Established in 2001 and headquartered in San Diego, WBB Securities is a registered independent broker-dealer and investment advisor with proprietary trading desks that have market-making capabilities.  WBB Securities has built a nationwide team of respected senior investment and research professionals with a network of branches throughout the U.S. to serve institutional and high net worth clients.
 
The firm also maintains an investment banking and equity research practice focused exclusively in the life sciences niche.  Our investment bank has participated in over 120 transactions leading to $3 billion placed.  Whether raising capital or executing strategic transactions, our banking team is equipped to meet your financial needs and is comprised of some of the most knowledgeable people working in the life sciences domain.  Our firm has been distinguished from it peers for its equity research and analytics year after year for accuracy and performance by the financial industry's most highly regarded rankings organizations. 
Wbb securities
Managing director 

Ms Kate Hogerton United States

Bellevue Hospital is the oldest continuously operating hospital in America. We trace our roots back to 1736 when a six-bed infirmary opened on the second floor of the New York City Almshouse. This was just four years after the birth of George Washington and 40 years before the signing of the Declaration of Independence.

Since its humble beginnings as a haven for the indigent, Bellevue has become a major academic medical institution of international renown. Over the centuries, we served as an incubator for major innovations in public health, medical science and medical education. Often referred to as a national treasure, Bellevue defines the very best traditions of public medicine as a public service vital to the well being of our civil society.

Bellevue Hospital Center
LinkedIn logo Associate Executive Director 

Hayden Yao-Ting Huang PhD, MPH United States

​LinkedIn Profile

http://www.linkedin.com/pub/hayden-y-t-huang/22/227/913

Memorial Sloan-Kettering Cancer Center
LinkedIn logo Principal Investigator: Patients Engagement in Clinical Trials. Co-Principal Investigator: Infections Burden on Cancer Patients 

Todd Hudson United States

TNT (Tactile Navigation Tools, LLC) creates and commercializes superior assistive technology for those with visual impairment. Currently, the tools and devices offered are antiquated and inadequate for the challenges of the visually disabled, preventing health optimization by many. 

We have tools that simplify training, increase mobility, and permit functional independence. The founder is a disability physician living with visual impairment and the team combines rehabilitation medicine, engineering, computer modeling and psychophysics.

Tactile Navigation Tools
CTO 

Anne HUMMLER France

Inferential  Biostatistical expertise and services for all types of studies Industry sectors Other: Biostatistics Therapeutics Area Cardiology / Vascular Diseases
CNS-Neurology
Dental and Oral Health
Dermatology
Endocrinology
Gastroenterology / Hepatology
Immunology
Infectious Diseases - Vaccines
Ivd / Diagnostics
Nutrition and Weight Loss
Obstetrics/Gynecology (Women's Health)
Oncology
Ophthalmology
Orthopedics/Orthopedic Surgery
Otolaryngology (Ear, Nose, Throat)
Pulmonary/Respiratory Diseases
Rare Disease
Psychiatry/Psychology
Rheumatology
Your innovative solution

Inferential provides statistical expertise and delivers results and statistical reports for any type of study incl clinical, NIS, health-economics, epidemiology

Which problem are you solving ?

While health authorities are more and more demanding in terms of data quality and study standards, most pharmaceutical companies own less and less skilled statistical resources. Inferential acts as the client's own statistical department or an extension thereof.

Target market segments

1)Pharmaceutical companies 2)Biotechs 3) Device 4) Cosmetics and nutrition 5) Vet

Key value proposition

1) Hign expertise with low overhead costs 2) Broad experience in both US and EMEA regulatory context

Inferential
CEO 

Kevin Ikechi Nigeria

Procurement and Logistics experts.

Sugish International LTD
Manager 

Philippe JAIS France

Innovative non-viral non-integrative gene therapy and DNA vaccination for treatment of severe human diseases based on proprietary set of expression technologies

Eukarys
CEO, CSO